Andere Sprachen Autolus Therapeutics plc

Aktien

A2JNZJ

US05280R1005

AUTL

Verzögert Nasdaq Andere Börsenplätze 22:00:00 24.05.2024			% 5 Tage	% 1. Jan.
3,92 ^USD	+1,29 %		-10,71 %	-39,13 %

23.05.	Tech-Aktien führen europäische Aktien an, die in den USA als American Depositary Receipts gehandelt werden, und steigen im Donnerstagshandel	MT
21.05.	Europäische Aktien, die in den USA als American Depositary Receipts gehandelt werden, tendieren im Dienstagshandel leicht höher	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Tech Stocks Lead European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading	23.05.
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Tuesday Trading	21.05.
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Friday Trading	17.05.
Syncona notes Autolus's first quarter loss widens amid higher costs	17.05.
Sector Update: Health Care Stocks Steady Pre-Bell Friday	17.05.
Exchange-Traded Funds, Equity Futures Tread Water Pre-Bell Friday Amid Waning September Rate Cut Hopes	17.05.
Autolus Therapeutics' Q1 Loss Widens, Licensing Revenue Rises	17.05.
Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates	17.05.
Autolus Therapeutics plc Reports Earnings Results for the First Quarter Ended March 31, 2024	17.05.
European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading	16.05.
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Wednesday Trading	15.05.
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Tuesday Trading	14.05.
Autolus Therapeutics to Present Three Clinical Data Updates on obecabtagene autoleucel (obe-cel) in relapsed/refractory (r/r) B-Cell acute lymphoblastic leukemia (ALL) patients at the 2024 European Hematology Association (EHA) Congress	14.05.
Autolus Therapeutics to Present Three Clinical Data Updates on obecabtagene autoleucel (obe-cel) in relapsed/refractory (r/r) B-Cell acute lymphoblastic leukemia (ALL) patients at the 2024 European Hematology Association (EHA) Congress	14.05.
Autolus Therapeutics Announces Delay of Q1 Earnings Release	13.05.
European Equities Traded in the US as American Depositary Receipts Kick Off Week Higher	13.05.
Autolus Therapeutics Announces Delay to its First Quarter 2024 Earnings Release and Conference Call	13.05.
Autolus Therapeutics Announces Delay to its First Quarter 2024 Earnings Release and Conference Call	13.05.
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading	09.05.
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Wednesday Trading	08.05.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Autolus Therapeutics plc

Aktien

A2JNZJ

US05280R1005

AUTL

Andere Sprachen

Filter